Contributors | p. vii |
Antigen Presentation by CD1: Lipids, T Cells, and NKT Cells in Microbial Immunity | p. 1 |
Introduction | p. 3 |
The CD1 Antigen Presentation Pathway: Chemistry, Structure, and Cell Biology | p. 3 |
Group I CD1: CD1a, b, and c Molecules and T Cells | p. 28 |
Group II CD1: CD1d-Restricted T Cells: Activation, Function, and Role in Antimicrobial Immunity | p. 35 |
Role of CD1d-Restricted NKT Cells in Specific Microbial Infections | p. 49 |
Conclusions | p. 68 |
Acknowledgments | p. 70 |
References | p. 70 |
How the Immune System Achieves Self-Nonself Discrimination During Adaptive Immunity | p. 95 |
Introduction | p. 97 |
Is Peripheral Immune Regulation Necessary for Self-Nonself Discrimination? | p. 99 |
Self-Nonself Discrimination Achieved During Thymic Negative Selection Determines How the Adaptive Immunity Is Regulated in the Periphery to Maintain Self-tolerance | p. 109 |
The Impact of the Conceptual Framework of the "Avidity Model" on the Development and Control of Pathogenic Autoimmunity | p. 118 |
Acknowledgments | p. 127 |
References | p. 127 |
Cellular and Molecular Mechanisms in Atopic Dermatitis | p. 135 |
Introduction | p. 136 |
Physiology and Immunology of Normal Skin | p. 137 |
Clinical Aspects of AD | p. 143 |
Epidemiology | p. 151 |
Genetics | p. 153 |
Pathophysiology of AD | p. 158 |
Animal Models of AD | p. 171 |
Treatment of AD | p. 201 |
Conclusion | p. 203 |
Acknowledgments | p. 204 |
References | p. 204 |
Micromanagers of Immune Cell Fate and Function | p. 227 |
Introduction | p. 228 |
miRNA Biogenesis | p. 228 |
miRNA Regulation of Gene Expression | p. 229 |
miRNA Target Genes | p. 230 |
miRNAs Regulate Hematopoietic Differentiation and Immune Function | p. 231 |
miRNA Regulation of Lymphocyte Development and Function | p. 234 |
miRNA Regulation of Inflammatory Responses | p. 235 |
Viruses Harness the miRNA Machinery | p. 235 |
Some Viral miRNAs Mimic Host miRNAs | p. 237 |
Host miRNAs also Regulate Viral Replication | p. 237 |
Prospects for Manipulating miRNA Function for Immunomodulatory Therapy | p. 238 |
Acknowledgment | p. 239 |
References | p. 239 |
Immune Pathways for Translating Viral Infection into Chronic Airway Disease | p. 245 |
Introduction | p. 246 |
Background for the Model | p. 249 |
cDC T Cell Immune Axis | p. 251 |
NKT Cell-Macrophage Immune Axis | p. 258 |
Summary | p. 269 |
Acknowledgments | p. 272 |
References | p. 272 |
Index | p. 277 |
Contents of Recent Volumes | p. 285 |
Table of Contents provided by Ingram. All Rights Reserved. |